A detailed history of New England Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, New England Asset Management Inc holds 18,850 shares of AMGN stock, worth $5.86 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
18,850
Previous 18,200 3.57%
Holding current value
$5.86 Million
Previous $5.24 Million 2.25%
% of portfolio
0.87%
Previous 0.88%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $174,765 - $210,964
650 Added 3.57%
18,850 $5.36 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $153,420 - $173,076
600 Added 3.41%
18,200 $5.24 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $360,772 - $447,908
-1,650 Reduced 8.57%
17,600 $4.73 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $2.65 Million - $3.23 Million
11,750 Added 156.67%
19,250 $4.65 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $1.6 Million - $2.04 Million
6,999 Added 1397.01%
7,500 $1.97 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $220,195 - $248,340
-981 Reduced 66.19%
501 $113,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $115,585 - $128,626
501 Added 51.07%
1,482 $361,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $87,708 - $97,028
-400 Reduced 28.96%
981 $237,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $113,361 - $129,732
-570 Reduced 29.22%
1,381 $311,000
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $208,236 - $243,974
981 Added 101.13%
1,951 $415,000
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $162,271 - $185,270
970
970 $181,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New England Asset Management Inc Portfolio

Follow New England Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.